Form 4 for ELVN Enliven Therapeutics, Inc.
Accepted 2024-08-02 00:00:00 ET · period of report 2024-07-31 · accession 0001415889-24-020685 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-08-02 | 2024-07-31 | ELVN | Heyman Richard A. | Dir | S - Sale | $27.50 | -649 | 27.9K | -2% | -$17.8K |
| 2024-08-02 | 2024-07-31 | ELVN | Heyman Richard A. | Dir | S - Sale | $27.51 | -1,702 | 131.6K | -1% | -$46.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-31 | S | D | 649 | $27.50 | 27,918 | I See footnote | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $27.50 to $27.51. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. (F4) The shares are held of record by RAHD Capital LLC for which the Reporting Person serves as a managing member. |
| 2 | Common | Common Stock | 2024-07-31 | S | D | 1,702 | $27.51 | 131,643 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $27.50 to $27.655. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |